Last reviewed · How we verify
Ropivacaine 0.2% Injectable Solution ESPB — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ropivacaine 0.2% Injectable Solution ESPB (Ropivacaine 0.2% Injectable Solution ESPB) — Poznan University of Medical Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ropivacaine 0.2% Injectable Solution ESPB TARGET | Ropivacaine 0.2% Injectable Solution ESPB | Poznan University of Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ropivacaine 0.2% Injectable Solution ESPB CI watch — RSS
- Ropivacaine 0.2% Injectable Solution ESPB CI watch — Atom
- Ropivacaine 0.2% Injectable Solution ESPB CI watch — JSON
- Ropivacaine 0.2% Injectable Solution ESPB alone — RSS
Cite this brief
Drug Landscape (2026). Ropivacaine 0.2% Injectable Solution ESPB — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivacaine-0-2-injectable-solution-espb. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab